Latest News | Biocon Q2 Net Profit Down 23 Pc at Rs 195 Cr
Get latest articles and stories on Latest News at LatestLY. Biotechnology major Biocon on Friday reported a 23.01 per cent fall in its consolidated net profit to Rs 195.4 crore for the second quarter ended September 30, mainly on account of higher expenses.
New Delhi, Oct 23 (PTI) Biotechnology major Biocon on Friday reported a 23.01 per cent fall in its consolidated net profit to Rs 195.4 crore for the second quarter ended September 30, mainly on account of higher expenses.
It had posted a net profit of Rs 253.8 crore for the July-September quarter previous fiscal, Biocon said in a late-night BSE filing on Thursday.
Also Read | Apple iPhone 12 & iPhone 12 Pro India Pre-Orders Now Open via Official Online Store.
Its consolidated total income stood at Rs 1,760.3 crore for the quarter under consideration. It was Rs 1,605.7 crore for the same period a year ago, it added.
"Our profitability was impacted on account of higher R&D expenses, staff costs, other expenses and forex losses. However, our core EBITDA margins stood at a healthy 32 per cent, indicating sound operational performance," Biocon Executive Chairperson Kiran Mazumdar-Shaw said.
Also Read | LG Wing Dual-Rotating Screen Smartphone to Be Launched in India on October 28, 2020.
As a part of our commitment to address the novel coronavirus pandemic in India, the Biocon Group is working on a comprehensive portfolio of products for treating mild to severely ill COVID-19 patients, she added.
"Our Insulin Glargine, Semglee was commercialised in the US by our partner Mylan, during the quarter, thus heralding our entry into the US Insulins market. With this launch, we have expanded our portfolio of Biosimilars and occupy a position of impactful influence in the Biosimilars segment," Mazumdar-Shaw said.
The R&D expense of the company for the quarter ended September 30, 2020, was at Rs 148 crore as against Rs 104 crore in the same period of the previous fiscal, Biocon said.
Shares of Biocon were trading at Rs 421.55 per scrip on BSE, down 1.85 per cent from its previous close. PTI AKT
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)